Your browser doesn't support javascript.
loading
Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review.
Sanabria, Alvaro; Pinillos, Pilar; Lira, Renan B; Shah, Jatin P; Tufano, Ralph P; Zafereo, Mark E; Nixon, Iain J; Randolph, Gregory W; Simo, Ricard; Vander Poorten, Vincent; Rinaldo, Alessandra; Medina, Jesus E; Khafif, Avi; Angelos, Peter; Mäkitie, Antti A; Shaha, Ashok R; Rodrigo, Juan P; Hartl, Dana M; Kowalski, Luiz P; Ferlito, Alfio.
Afiliação
  • Sanabria A; Department of Surgery, School of Medicine, Universidad de Antioquia/IPS Universitaria/Hospital Universitario San Vicente Fundación, Medellín, Colombia.
  • Pinillos P; CEXCA Centro de Excelencia en Enfermedades de Cabeza y Cuello/Clínica Las Vegas-grupo Quirónsalud, Medellín, Colombia.
  • Lira RB; Department of Surgery, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia-Hospital Universitario Nacional de Colombia, Bogotá, Colombia.
  • Shah JP; Head and Neck Surgery and Otorhinolaryngology Department, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Tufano RP; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Zafereo ME; Department of Oncology, Radiotherapy and Plastic Surgery, Sechenov University, Moscow, Russia.
  • Nixon IJ; Director of the FPG Thyroid and Parathyroid Center, Division of Head and Neck Endocrine Surgery, The Sarasota Memorial Health Care System, Sarasota, Florida, USA.
  • Randolph GW; Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
  • Simo R; Department of Otorhinolaryngology Head and Neck Surgery, Edinburgh Royal Infirmary, Edinburgh, UK.
  • Vander Poorten V; Thyroid/Parathyroid Endocrine Surgical Division, Thyroid Surgical Oncology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
  • Rinaldo A; Department of Otorhinolaryngology-Head and Neck Surgery, Guy's and St Thomas' Hospital NHS Foundation Trust, King's College London, London, UK.
  • Medina JE; Otorhinolaryngology Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.
  • Khafif A; Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium.
  • Angelos P; University of Udine School of Medicine, Udine, Italy.
  • Mäkitie AA; Department of Otolaryngology and Head and Neck Surgery, The University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA.
  • Shaha AR; Head and Neck Surgery and Oncology Unit, A.R.M. Center for Advanced Otolaryngology Head and Neck Surgery, Assuta Medical Center, Tel Aviv, Israel.
  • Rodrigo JP; Department of Surgery and MacLean Center for Clinical Medical Ethics, The University of Chicago, Chicago, Illinois, USA.
  • Hartl DM; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Kowalski LP; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Ferlito A; Department of Otolaryngology, Hospital Universitario Central de Asturias-ISPA, Oviedo, Spain.
Head Neck ; 44(1): 226-237, 2022 01.
Article em En | MEDLINE | ID: mdl-34590380
Most cases of thyroid carcinoma are classified as low risk. These lesions have been treated with open surgery, remote access thyroidectomy, active surveillance, and percutaneous ablation. However, there is lack of consensus and clear indications for a specific treatment selection. The objective of this study is to review the literature regarding the indications for management selection for low-risk carcinomas. Systematic review exploring inclusion and exclusion criteria used to select patients with low-risk carcinomas for treatment approaches. The search found 69 studies. The inclusion criteria most reported were nodule diameter and histopathological confirmation of the tumor type. The most common exclusions were lymph node metastasis and extra-thyroidal extension. There was significant heterogeneity among inclusion and exclusion criteria according to the analyzed therapeutic approach. Alternative therapeutic approaches in low-risk carcinomas can be cautiously considered. Open thyroidectomy remains the standard treatment against which all other approaches must be compared.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Papilar Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Head Neck Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Papilar Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Head Neck Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos